XT
BCAB icon

XTX Topco’s BioAtla BCAB Stock Holding History

XTX Topco’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.12K Sell
1,132
-76
-6% -$889 ﹤0.01% 3708
2025
Q4 		$34.3K Buy
1,208
+820
+211% +$32.1K ﹤0.01% 2929
2025
Q3 		$13.3K Buy
+388
New +$8.96K ﹤0.01% 2399
2024
Q4 		– Sell
-3,099
Closed -$273K – 2297
2024
Q3 		$273K Buy
3,099
+207
+7% +$17.4K 0.02% 1254
2024
Q2 		$198K Sell
2,892
-395
-12% -$47K 0.02% 1246
2024
Q1 		$565K Buy
+3,287
New +$408K 0.08% 421
2023
Q4 		– Sell
-740
Closed -$62.9K – 1602
2023
Q3 		$62.9K Sell
740
-1,470
-67% -$187K 0.01% 1249
2023
Q2 		$332K Buy
+2,210
New +$380K 0.06% 644
2022
Q3 		– Sell
-745
Closed -$106K – 1104
2022
Q2 		$106K Buy
745
+382
+105% +$60.8K 0.04% 628
2022
Q1 		$91K Buy
+363
New +$152K 0.04% 527

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's BCAB Position: Q1 2026 in Review

XTX Topco reduced its BioAtla (BCAB) stake by 6.3% in Q1 2026, selling an estimated $889 and leaving 1,132 shares worth $9.12K. The position accounts for ﹤0.01% of the portfolio, ranked #3708.

XTX Topco first reported a position in BCAB in Q1 2022 and has held it in 10 quarters since. The position peaked at $565K in Q1 2024. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • XTX Topco held 1,132 shares of BioAtla worth $9.12K as of Q1 2026.
  • XTX Topco sold 76 BioAtla shares in Q1 2026, an estimated $889.
  • BioAtla made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3708 holding.
  • XTX Topco first reported a position in BioAtla in Q1 2022 and has held it in 10 quarters since.
  • XTX Topco's BioAtla position peaked at $565K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.